{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:51:35Z","timestamp":1779889895714,"version":"3.53.1"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"abstract":"<jats:p>Sickle cell disease (SCD) is the most common inherited condition worldwide. In the United States, SCD affects 100,000 births every year, mostly persons of African descent. In SCD, red blood cells assume a sickle shape when deoxygenated. This leads to the occlusion of small blood vessels and decreased oxygenated blood flow, resulting in ischemic and thrombotic injury to various organs, which further leads to organ dysfunction. In pregnancy, patients with SCD are at an increased risk of vaso-occlusive crises, which further increases the risks of maternal, fetal, and neonatal morbidity and mortality.<\/jats:p>","DOI":"10.1542\/neo.24-6-e452","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T03:04:12Z","timestamp":1688180652000},"page":"e452-e457","source":"Crossref","is-referenced-by-count":1,"title":["Sickle Cell Crises in Pregnancy: Fetal and Neonatal Implications"],"prefix":"10.1542","volume":"24","author":[{"given":"Ashley Appiagyei","family":"Cole","sequence":"first","affiliation":[{"name":"*Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA"},{"name":"\u2020Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Wagner","sequence":"additional","affiliation":[{"name":"*Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA"},{"name":"\u2020Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Gupta","sequence":"additional","affiliation":[{"name":"*Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA"},{"name":"\u2020Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"issue":"16","key":"2023070103040115900_b1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"2023070103040115900_b2","unstructured":"Centers for Disease Control and Prevention. Data & Statistics on Sickle Cell Disease. https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html. Accessed April 14, 2023"},{"issue":"10","key":"2023070103040115900_b3","first-page":"CD010849","article-title":"Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease","volume":"10","author":"Hussein","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"22","key":"2023070103040115900_b4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2018-06-848705","article-title":"The current state of sickle cell trait: implications for reproductive and genetic counseling","volume":"132","author":"Pecker","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2023070103040115900_b5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/ejh.13430","article-title":"The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management","volume":"105","author":"Darbari","year":"2020","journal-title":"Eur J Haematol"},{"issue":"5","key":"2023070103040115900_b6","first-page":"1404","article-title":"Autosplenectomy in severity of sickle cell diseases","volume":"7","author":"Helvaci","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"2023070103040115900_b7","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.ajog.2008.04.016","article-title":"Morbidity associated with sickle cell disease in pregnancy","volume":"199","author":"Villers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2023070103040115900_b8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00006250-200701000-00055","article-title":"ACOG Practice Bulletin No. 78: hemoglobinopathies in pregnancy","volume":"109","author":"ACOG Committee on Obstetrics","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2023070103040115900_b9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/1471-0528.13786","article-title":"Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis","volume":"123","author":"Boafor","year":"2016","journal-title":"BJOG"},{"issue":"5","key":"2023070103040115900_b10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193.x","article-title":"Guidelines for the management of the acute painful crisis in sickle cell disease","volume":"120","author":"Rees","year":"2003","journal-title":"Br J Haematol"},{"issue":"6","key":"2023070103040115900_b11","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1097\/AOG.0000000000002662","article-title":"ACOG Committee Opinion No. 741: Maternal Immunization","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2023070103040115900_b12","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1111\/bjh.17798","article-title":"Concordance with comprehensive iron assessment, hepatitis A vaccination, and hepatitis B vaccination recommendations among patients with sickle cell disease and thalassaemia receiving chronic transfusions: an analysis from the Centers for Disease Control haemoglobinopathy blood safety project","volume":"195","author":"Badawy","year":"2021","journal-title":"Br J Haematol"},{"issue":"5","key":"2023070103040115900_b13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ajh.26495","article-title":"Pregnancy outcomes with hydroxyurea use in women with sickle cell disease","volume":"97","author":"Kroner","year":"2022","journal-title":"Am J Hematol"},{"issue":"6","key":"2023070103040115900_b14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/GIM.0b013e31821d4188","article-title":"Policy statement on folic acid and neural tube defects","volume":"13","author":"Toriello","year":"2011","journal-title":"Genet Med"},{"issue":"1","key":"2023070103040115900_b15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s12884-020-03326-8","article-title":"Iron stores in pregnant women with sickle cell disease: a systematic review","volume":"20","author":"Aroke","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"2023070103040115900_b16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"2023070103040115900_b17","doi-asserted-by":"crossref","first-page":"742","DOI":"10.14423\/SMJ.0000000000000900","article-title":"Maternal\/perinatal outcome in women with sickle cell disease: a comparison of two time periods","volume":"111","author":"Chang","year":"2018","journal-title":"South Med J"},{"issue":"12","key":"2023070103040115900_b18","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"2023070103040115900_b19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.ajog.2005.11.022","article-title":"Bacteriuria in pregnant women with sickle cell trait","volume":"194","author":"Thurman","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2023070103040115900_b20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/01443615.2019.1647524","article-title":"Acute pyelonephritis during pregnancy: a systematic review of the aetiology, timing, and reported adverse perinatal risks during pregnancy","volume":"40","author":"Grette","year":"2020","journal-title":"J Obstet Gynaecol"},{"issue":"6","key":"2023070103040115900_b21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/bjh.17607","article-title":"Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data","volume":"194","author":"Malinowski","year":"2021","journal-title":"Br J Haematol"},{"issue":"6","key":"2023070103040115900_b22","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1097\/AOG.0000000000004407","article-title":"Indications for outpatient antenatal fetal surveillance: ACOG committee opinion, number 828","volume":"137","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Obstetric Practice, Society for Maternal-Fetal Medicine","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"9","key":"2023070103040115900_b23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1055\/s-0028-1085628","article-title":"Acute chest syndrome during pregnancy as initial presentation of sickle cell disease: a case report","volume":"25","author":"Campbell","year":"2008","journal-title":"Am J Perinatol"},{"issue":"4","key":"2023070103040115900_b24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cpem.2010.09.002","article-title":"Evaluation and treatment of sickle cell pain in the emergency department: paths to a better future","volume":"11","author":"Zempsky","year":"2010","journal-title":"Clin Pediatr Emerg Med"},{"issue":"2","key":"2023070103040115900_b25","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee opinion no. 711: opioid use and opioid use disorder in pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"22","key":"2023070103040115900_b26","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv"},{"issue":"12","key":"2023070103040115900_b27","first-page":"CD010378","article-title":"Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy","volume":"12","author":"Okusanya","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2023070103040115900_b28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cnc.2017.04.012","article-title":"The risks associated with red blood cell transfusion: implications for critical care practice","volume":"29","author":"Sutton","year":"2017","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"2","key":"2023070103040115900_b29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"2023070103040115900_b30","doi-asserted-by":"crossref","first-page":"e2018032","DOI":"10.4084\/mjhid.2018.032","article-title":"Perioperative management of sickle cell disease","volume":"10","author":"Adjepong","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"6","key":"2023070103040115900_b31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/bjh.17671","article-title":"Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline","volume":"194","author":"Oteng-Ntim","year":"2021","journal-title":"Br J Haematol"},{"issue":"1","key":"2023070103040115900_b32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajh.25626","article-title":"Perioperative care of children with sickle cell disease: A systematic review and clinical recommendations","volume":"95","author":"Schyrr","year":"2020","journal-title":"Am J Hematol"},{"issue":"1","key":"2023070103040115900_b33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1182\/hematology.2021000307","article-title":"Indications for transfusion in the management of sickle cell disease","volume":"2021","author":"Han","year":"2021","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"issue":"2 Pt 2","key":"2023070103040115900_b34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/AOG.0b013e3182267e58","article-title":"Epidural analgesia for treatment of a sickle cell crisis during pregnancy","volume":"118","author":"Winder","year":"2011","journal-title":"Obstet Gynecol"}],"container-title":["NeoReviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/24\/7\/e452\/1490029\/neoreviews.022023mfcs00014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/neoreviews\/article-pdf\/24\/7\/e452\/1490029\/neoreviews.022023mfcs00014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T03:04:25Z","timestamp":1688180665000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/neoreviews\/article\/24\/7\/e452\/192311\/Sickle-Cell-Crises-in-Pregnancy-Fetal-and-Neonatal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,1]]},"published-print":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/neo.24-6-e452","relation":{},"ISSN":["1526-9906"],"issn-type":[{"value":"1526-9906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]}}}